Healthcare Organizations Call for FDA Action on Compounding Regulations Amid GLP-1 Shortages
March 23, 2025 - 10:21
Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) have taken a significant step by sending a letter to the U.S. Food and Drug Administration (FDA). This letter, supported by over 20 prominent organizations and providers from various sectors of healthcare, emphasizes the urgent need for the FDA to implement and enforce federal regulations concerning compounding practices.
The call to action comes in the wake of recent shortages of GLP-1 medications, which are crucial for the treatment of obesity and related conditions. These shortages have raised serious concerns about patient access to essential therapies. The coalition argues that without stricter oversight and regulation of compounded medications, patients may face continued disruptions in their treatment options.
Healthcare leaders are advocating for a timely response from the FDA to ensure that patients receive the medications they need without interruption, highlighting the importance of regulatory frameworks in safeguarding public health.
MORE NEWS
August 12, 2026 - 08:26
Rod Stewart's Iowa State Fair concert canceled over health issuesFans hoping to catch Rod Stewart at the Iowa State Fair this summer will need to make other plans. Organizers confirmed on Tuesday that the legendary singer`s August performance has been called off...
August 11, 2026 - 17:11
Dietitian Shares No. 1 Plant-Based Protein to Boost Brain HealthWhen people think about protein for brain health, they often picture eggs or salmon. But a growing number of nutrition experts are pointing to a humble plant source that does double duty: it fights...
August 11, 2026 - 04:10
What alcohol is consumed — not just how muchA recent analysis has shifted the conversation around drinking and health, focusing not just on how much people drink, but on what they are actually consuming. The findings suggest that the type of...
August 10, 2026 - 16:50
Nature Medicine Just Published the AI Mental Health Audit Framework the FDA Hasn’t Written YetA new framework for evaluating artificial intelligence chatbots used in mental health care has been published in Nature Medicine, offering a structured method for clinical trials that the FDA has...